Citizen Petition from American College of Obstetricians and Gynecologists

The Boston University School of Law's various legal programs submit a supplemental comment supporting the removal of the Mifepristone Shared System Risk Evaluation and Mitigation Strategy (REMS). They argue that restricting access to mifepristone increases intimate partner violence (IPV) and imposes significant social and economic burdens, particularly on marginalized and low-income communities.

RHITES (Reproductive Health Initiative for Telehealth Equity & Solutions) supports the citizen petitions requesting that the FDA eliminate restrictions on mifepristone access under the Single Shared System REMS Program. They argue that telehealth for medication abortion is safe, effective, and provides critical benefits by reducing travel burdens, costs, and stigma for patients.

Legal Voice, Family Violence Appellate Project, Sexual Violence Law Center, and the Washington State Coalition Against Domestic Violence submit a joint comment in support of a petition to remove the Mifepristone Shared System Risk Evaluation and Mitigation Strategy (REMS). They argue that maintaining easy access to mifepristone, particularly through telehealth and mail delivery, is critical for the safety and reproductive autonomy of survivors of intimate partner violence (IPV) and marginalized communities.